Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

1615results about How to "Mass production" patented technology

Fabrication method for a thin film semiconductor device, the thin film semiconductor device itself, liquid crystal display, and electronic device

In order to fabricate a high performance thin film semiconductor device using a low temperature process in which it is possible to use low price glass substrates, a thin film semiconductor device has been fabricated by forming a silicon film at less than 450 DEG C., and, after crystallization, keeping the maximum processing temperature at or below 350 DEG C. In applying the present invention to the fabrication of an active matrix liquid crystal display, it is possible to both easily and reliably fabricate a large, high-quality liquid crystal display. Additionally, in applying the present invention to the fabrication of other electronic circuits as well, it is possible to both easily and reliably fabricate high-quality electronic circuits.
Owner:INTELLECTUAL KEYSTONE TECH

Electric part and method of manufacturing the same

There are provided an electric part which can be produced through a production process which is excellent in an industrial productivity and a method of manufacturing the electric part, by including a matrix-shaped nonconductive base member, a carbon nanotube group that is sealed within the nonconductive base member and includes one carbon nanotube or plural carbon nanotubes which are electrically connected to each other, in which substantially only end portion of the one carbon nanotube or at least one carbon nanotube contained in the plural carbon nanotubes is exposed from one surface of the nonconductive base member, and an electrode that is connected to a side surface of the at least one carbon nanotube contained in the carbon nanotube group.
Owner:FUJIFILM BUSINESS INNOVATION CORP

Delivery of therapeutic biologicals from implantable tissue matrices

InactiveUS6692738B2Many of effectMany of inconvenienceBiocidePowder deliveryProgenitorActive agent
Normal cells, such as fibroblasts or other tissue or organ cell types, are genetically engineered to express biologically active, therapeutic agents, such as proteins that are normally produced in small amounts, for example, MIS, or other members of the TGF-beta family Herceptin(TM), interferons, andanti-angiogenic factors. These cells are seeded into a matrix for implantation into the patient to be treated. Cells may also be engineered to include a lethal gene, so that implanted cells can be destroyed once treatment is completed. Cells can be implanted in a variety of different matrices. In a preferred embodiment, these matrices are implantable and biodegradable over a period of time equal to or less than the expected period of treatment, when cells engraft to form a functional tissue producing the desired biologically active agent. Implantation may be ectopic or in some cases orthotopic. Representative cell types include tissue specific cells, progenitor cells, and stem cells. Matrices can be formed of synthetic or natural materials, by chemical coupling at the time of implantation, using standard techniques for formation of fibrous matrices from polymeric fibers, and using micromachining or microfabrication techniques. These devices and strategies are used as delivery systems via standard or minimally invasive implantation techniques for any number of parenterally deliverable recombinant proteins, particularly those that are difficult to produce in large amounts and / or active forms using conventional methods of purification, for the treatment of a variety of conditions that produce abnormal growth, including treatment of malignant and benign neoplasias, vascular malformations (hemangiomas), inflammatory conditions, keloid formation, abdominal or plural adhesions, endometriosis, congenital or endocrine abnormalities, and other conditions that can produce abnormal growth such as infection. Efficacy of treatment with the therapeutic biologicals is detected by determining specific criteria, for example, cessation of cell proliferation, regression of abnormal tissue, or cell death, or expression of genes or proteins reflecting the above.
Owner:THE GENERAL HOSPITAL CORP

Microstructured optical device for polarization and wavelength filtering

A microstructure-based polarizer is described. The device acts as an electromagnetic wave filter in the optical region of the spectrum, filtering multiple wavelength bands and polarization states. The apparatus comprises a substrate having a surface relief structure containing dielectric bodies with physical dimensions smaller than the wavelength of the filtered electromagnetic waves, such structures repeated in an array covering at least a portion of the surface of the substrate. The disclosed structure is particularly useful as a reflective polarizer in a liquid crystal display, or as polarizing color filter elements at each pixel in a display. Other applications such as polarization encoded security labels, polarized room lighting, and color filter arrays for electronic imaging systems are made practical by the device.
Owner:HOBBS DOUGLAS S

Reconfigurable base station using mobile station RF ASIC

A reconfigurable RF transceiver for use in either a base station or a mobile station Of a wireless network. The reconfigurable RF transceiver comprises a first receive path that down-converts an incoming RF signal to analog and digital baseband signals. The first receive path in a first mode down-converts the incoming RF signal in a receive frequency band for the base station and in a second mode down-converts the incoming RF signal in a receive frequency band for the mobile station. The reconfigurable RF transceiver further comprises a transmit path for up-converting an outgoing baseband signal to an outgoing RF signal. The transmit path in the first mode up-converts the outgoing baseband signal in a transmit frequency band for the base station and in the second mode up-converts the outgoing baseband signal in a transmit frequency band for the mobile station.
Owner:SAMSUNG ELECTRONICS CO LTD

Hydrogen production from an oxyfuel combustor

InactiveUS20070044479A1Low costDemanded electric powerHydrogenGas turbine plantsChemistryCarbon dioxide
A system is provided for hydrogen production from a hydrogen and carbon containing fuel combusted within an oxyfuel combustor. The oxyfuel combustor combusts hydrogen and carbon containing fuel with oxygen at a non-stoichiometric ratio, typically fuel rich. In such an operating mode, products of combustion include steam, carbon dioxide, carbon monoxide and hydrogen. These products of combustion are then passed through a hydrogen separator where hydrogen is separated. Remaining products of combustion can be optionally combusted at a stoichiometric ratio with oxygen in a second oxyfuel combustor discharging substantially only steam and carbon dioxide. A turbine can be provided downstream from the gas generator to produce power and eliminate carbon monoxide from the system. The system can be operated in a second mode where the gas generator combusts the fuel with oxygen at a stoichiometric ratio to maximize electric power generation without hydrogen production at periods of peak electric power demand.
Owner:CLEAN ENERGY SYST

Protective shield for aircraft cockpit crew

This invention relates generally to the field of aircraft technology and systems utilized for protection of aircraft, occupants, and operators thereof from hijackers, terrorists, and other anomalous problems while in flight. More particularly, the present invention relates to a device used in conjunction with walls, floor, and ceiling of a cockpit's entry/exit passageway for protecting the cockpit crew from weapons, hostility, decompression, and/or physical intrusions. A light weight protective shield for the cockpit of an aircraft (i.e. bullet-proof door) along with a internal locking and release device, none of which is provided by prior art. The protective shield can absorb repeated blows, provide pressure relief in the event of aircraft decompression, resist penetration of firearms, knives, and explosive devices, and is compliant with FAA regulations. The protective shield provides a new level of protection for the crew of a passenger or cargo airplane and protects the cockpit of an aircraft from hijacking attempts as well as other anomalous events and is comprised of a light weight weapon-proof protective shield that when closed fits snugly with the flight deck's adjoining floor, walls, and ceiling. This protective shield system is intended to readily install inside existing aircraft (e.g. over-night retrofit installation) or be installed into new aircraft as they are assembled.
Owner:PITTMAN DONALD MERVE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products